Sensus Healthcare Superficial Radiotherapy System SRT-100
System, Therapeutic, X-Ray. 510(k) K123985, from Sensus Healthcare (Boca Raton, FL). Product code JAD, class 2.
As of Nov 20, 2026, K123985 is an FDA 510(k) held by Sensus Healthcare, substantially equivalent on May 14, 2013 after 139 days, with no recalls tied to it in FDA's recall database.
- Review time: 139 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The SRT-100 is a low energy X-ray system intended for superficial radiotherapy treatment of primary malignant epithelial neoplasms of the skin and keloids. Applications include basal cell carcinoma, squamous cell carcinoma, Metatypic carcinoma, cutaneous appendage carcinoma. Karposi's Sarcoma, and the treatment of keloids.
- SRT100 Superficial Radiation Therapy SystemK063456 · Topex, Inc. · Jan 9, 2007
- Therapax Sxt 150K971074 · Pantak, Inc. · Jun 13, 1997
- Darpac 2000 Superficial X-Ray Therapy SystemK962613 · Gulmay Medical , Ltd. · Sep 27, 1996
- Photoelectric Therapy SystemK172080 · Xstrahl, Ltd. · Sep 29, 2017
- Sensus Helthcare Image-Duided Superficial Radiotherapy SystemK131582 · Sensus Healthcare · Aug 28, 2013
- GentleBeam (GB1000)K250692 · Voxel Ray Solutions, LLC · Dec 3, 2025
- INTRABEAM (700); And accessories (INTRABEAM SMART Stand, INTRABEAM SMART Spherical Applicator, INTRABEAM Spherical…K241174 · Carl Zeiss Meditec, AG · Jan 10, 2025
- X80 / RADiant / PhotoElectric Therapy System (RADiant Aura)K230611 · Xstrahl, Ltd. · Jul 13, 2023
- EsteyaK213942 · Nucletron B.V. · Jan 11, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 26, 2012
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5900
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files